Genome Research Limited for the Wellcome Sanger Institute
Date of Award
08.10.2022
Program
Crohn's Disease, Therapeutics
Amount
$1,539,606
Term of Grant
36 months
Project Title
scIBD-RESPONSE: Massive-scale single-cell RNA-sequencing to identify transcriptomic predictors of response to biologic therapies in Crohn’s disease
Project Description
This grant aims to provide an understanding of CD genetics and gene expression at unprecedented scale and can pave the way to better predict patient response to therapeutics and provide new insight into disease mechanisms.